Liu B, Stepien S, Qian J, Gidding H, Nicolopoulos K, Amin J, Cheng A, Macartney K. Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection. Vaccine 2023;41:5483-5670. doi: 10.1016/j.vaccine.2023.07.050. [Full text]

Hull B, Hendry A, Dey A, Brotherton J, Macartney K, Beard F. Annual immunisation coverage report 2021 - 14 October 2022. Communicable Diseases Intelligence (2018) 2023;47. doi: 10.33321/cdi.2023.47.47. [Full text]

Pourmarzi D, Fitzpatrick P, Allen K, Yuen A, Lambert S. “They said we’re all in it together, but we were kind of separated”: barriers to access, and suggestions for improving access to official information about COVID-19 vaccines for migrants in Australia. BMC public health 2023;23:1690. doi: 10.1186/s12889-023-15739-z. [Full text]

Cardenas‐Brown C, Lucas RD, Buttery J, Britton PN, Wood N, Singh‐Grewal D, Burgner D. Live vaccines following intravenous immunoglobulin for Kawasaki disease: are we vaccinating appropriately? . Journal of Paediatrics and Child Health 2023. doi: 10.1111/jpc.16484 (Epub). [Full text]

Deng L, Tapper K, Thosar D, Goeman E, Baker L, Adelstein S, Boyle M, Brown DA, Evans L, Katelaris C, Lee F. Use of adrenaline to manage suspected anaphylaxis following COVID-19 vaccination: an Australian retrospective cohort study. Vaccine 2023. doi: 10.1016/j.vaccine.2023.08.024 (Epub). [Full text]

Phillips A, Jiang Y, Walsh D, Andrews N, Artama M, Clothier H, Cullen L, Deng L, Escolano S, Gentile A, Gidding G, Giglio N, Junker T, Huang W, Janjua N, Kwong J, Li J, Nasreen S, Naus M, Naveed Z, Pillsbury A, Stowe J, Vo T, Buttery J, Petousis-Harris H, Black S, Hviid A. Background rates of adverse events of special interest for COVID-19 vaccines: a multinational Global Vaccine Data Network (GVDN) analysis. Vaccine 2023. doi: 10.1016/j.vaccine.2023.08.079 (Epub). [Full text]

Wood N, Lopez L, Glover C, Leeb A, Cashman P, Deng L, Macartney K. Active safety surveillance of COVID-19 mRNA vaccines in children aged 5-15 years in Australia. Paediatrics 2023:100684. doi: 10.1016/j.lanwpc.2023.100684 (Epub). [Full text]

Pillay A, Yeola A, Tea F, Denkova M, Houston S, Burrell R, Merheb V, Lee FX, Lopez JA, Moran L, Jadhav A, Sterling K, Lai CL, Vitagliano TL, Aggarwal A, Catchpoole D, Wood N, Phan TG, Nanan R, Hsu P, Turville SG, Britton PN, Brilot F. Infection and vaccine induced spike antibody responses against SARS-CoV-2 variants of concern in COVID-19-naïve children and adults. Journal of Clinical Immunology 2023:1-8. doi: 10.1007/s10875-023-01540-5. [Full text]

Tran HA, Deng L, Wood N, Choi P, Singleton S, Clarke L, Khanlari S, Maitland-Scott I, Bird R, Brown S, Manoharan B, Tan CW, Gold M, Hissaria P, Melody S, Sanjeev D, Chunilal S, Buttery J, Clothier H, Crawford NW, Phuong L, Pepperell D, Effler P, Parker C, Carter N, Macartney K, McStea M, Miller T, Nissen M, Larter C, Kay E, Chen VM. The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based study. The Lancet Regional Health–Western Pacific 2023;40:100894. doi: 10.1016/j.lanwpc.2023.100894. [Full text]

Steffens M, Bullivant B, Kaufman J, King C, Danchin M, Hoq M, Marques MD. Testing persuasive messages about booster doses of COVID-19 vaccines: a randomised controlled trial. PLoS One 2023;18:e0286799. doi: 10.1371/journal.pone.0286799. [Full text]